SCHEMBL9529351

SCHEMBL9529351

CCCOc1nc(CC)n(Cc2ccc(-c3ccccc3-c3nnn[nH]3)cc2)n1

nearest known ligand 0.42

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
AGTR1 P30556 8/20 0.42
AGTR2 P50052 8/20 0.42
PDE5A O76074 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9531110 0.93 AGTR1 (0.45) AGTR1AGTR2
SCHEMBL9530979 0.92 AGTR1 (0.41) AGTR1AGTR2
SCHEMBL9528230 0.92 AGTR1 (0.52) AGTR1AGTR2
SCHEMBL9528071 0.91 AGTR1 (0.49) AGTR1AGTR2
SCHEMBL9527874 0.91 AGTR1 (0.41) AGTR1AGTR2PDE5A
SCHEMBL8109435 0.90 AGTR1 (0.39) AGTR1AGTR2PDE5A
SCHEMBL9529690 0.89 AGTR1 (0.42) AGTR1AGTR2
SCHEMBL9527994 0.89 AGTR1 (0.39) AGTR1AGTR2PDE5A
SCHEMBL9527981 0.89 AGTR1 (0.39) AGTR1AGTR2PDE5A
SCHEMBL9529395 0.89 AGTR1 (0.39) AGTR1AGTR2PDE5A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0527851-A1 1H-SUBSTITUTED-1,2,4-TRIAZOLE COMPOUNDS FOR TREATMENT OF CARDIOVASCULAR DISORDERS G.D. SEARLE & CO. (US) 1993-02-24 EP disclosed
US-5098920-A Hypotensive agents and treatment of congestive heart failure G. D. SEARLE & CO. (US) 1992-03-24 US disclosed
WO-1991017148-A1 1H-SUBSTITUTED-1,2,4-TRIAZOLE COMPOUNDS FOR TREATMENT OF CARDIOVASCULAR DISORDERS G.D. SEARLE & CO. (US) 1991-11-14 WO disclosed